Sohrab Fallahi
Rheumatology · Montgomery, ALNPI 1497739270
Payments from drug & device makers
Across 745 payments — averaging $33.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$12K
- AbbVie$3K
- Novartis$1K
- Johnson & Johnson$1K
- Pfizer$1K
- Mallinckrodt Hospital Products Inc.$876
- plus $5K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 122 | $11,774 |
| AbbVie | 161 | $3,299 |
| Novartis | 65 | $1,366 |
| Johnson & Johnson(2 entities) | 65 | $1,296 |
| Pfizer | 54 | $1,006 |
| Mallinckrodt Hospital Products Inc. | 29 | $876 |
| GSK | 43 | $865 |
| UCB, Inc. | 32 | $735 |
| AstraZeneca(2 entities) | 34 | $670 |
| Radius Health, Inc. | 25 | $487 |
| E.r. Squibb & Sons, L.L.C. | 24 | $449 |
| Aurinia Pharma U.S., Inc. | 16 | $374 |
| Genentech USA, Inc. | 18 | $355 |
| Boehringer Ingelheim | 12 | $295 |
| ANI Pharmaceuticals, Inc. | 6 | $173 |
| Fresenius Kabi USA, LLC | 7 | $132 |
| Octapharma USA, Inc. | 5 | $110 |
| Organon | 4 | $75 |
| Sanofi | 3 | $73 |
| Mallinckrodt Enterprises LLC | 3 | $66 |
| Bristol Myers Squibb | 3 | $62 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $48 |
| Hikma Pharmaceuticals USA | 3 | $48 |
| Janssen Scientific Affairs, LLC | 1 | $44 |
| Bioventus LLC | 1 | $25 |
| Mylan Institutional Inc. | 1 | $24 |
| Sobi, Inc | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
How this compares
$24,815 in reported general payments places this provider in the 75th percentile of 90 rheumatology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Montgomery
- James JakesMontgomery$12K
- Jacquelin ChuaMontgomery$6K
- Jeffrey CurtisBirmingham$17.6M
- Kenneth SaagBirmingham$8.2M
- Vishala ChindaloreAnniston$3.5M
- Anthony TurkiewiczMountain Brk$2.5M
- Harry SchroederBirmingham$938K
- Jose Rubio MosqueraBirmingham$823K
- David McLainBirmingham$588K
- William ShergyHuntsville$453K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.